Clinical Trial Update: Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing VCD to CTD in newly diagnosed multiple myeloma patients eligible for transplantation completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CTD
• VCD (Vacuum constriction device)

Snippet

Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia | Conditions: Multiple Myeloma, Effects of Chemotherapy | Phase 3 | Status: COMPLETED